glp-1 tirzepatide vs semaglutide vs. Semaglutide: What You Should Know tirzepatide vs semaglutide appetite suppression

At K&E MedSpa, our San Antonio patients achieve similar life-changing results under comprehensive physician supervision

Other research demonstrates that multi-hormone weight loss therapies targeting GLP-1, GIP, and glucagon are better at preserving muscle than medications targeting only one hormone

It also aids in weight loss, which is not a common feature of most diabetes medications.

GLP-1 Agonist Semaglutide Brand names: Ozempic (diabetes) Wegovy (weight loss) 1517% Average body weight reduction (STEP trials) Activates GLP-1 receptors in gut and brain Suppresses appetite, slows gastric emptying Regulates blood sugar and insulin response Weekly subcutaneous injection or daily oral (Rybelsus) Cardiovascular outcome data: SELECT trial (2023) Dual GLP-1 + GIP Agonist Tirzepatide Brand names: Mounjaro (diabetes) Zepbound (weight loss) 2022% Average body weight reduction (SURMOUNT trials) Activates both GLP-1 AND GIP receptors Stronger effect on insulin sensitivity than semaglutide alone Greater fat loss, especially visceral fat Weekly subcutaneous injection only Head-to-head vs semaglutide: SURPASS-6 favors tirzepatide The core difference is the receptor target

While the country still accounts for a third of the worlds undernutrition according to the World Health Organization (WHO), rising incomes and urban lifestyles have pushed obesity rates sharply upward